CMAC will be attending this workshop, which focuses on how Artificial Intelligence (AI) is transforming drug development and regulatory processes across the pharmaceutical industry.
Thomas McGlone, Ashley Jackson, and Kenny Smith will be attending CPHI Frankfurt this October.
CMAC’s Digital CMC CERSI team will be attending this conference, which highlights the use of artificial intelligence (AI) and machine learning (ML) across the value chain of solid oral dosage form development and manufacturing.
